Giant macrolactams based on β-sheet peptides

Journal of Organic Chemistry

Volumn 76, Issue 9, 2011, Pages 3166-3173

  Cheng, Pin Nan ^a   Nowick, James S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS SOLUTIONS; CHLORIDE RESIN; DEPROTECTION; LINEAR PEPTIDES; MACRO-CYCLIZATION; MACROCYCLES; NATURAL AMINO ACIDS; NMR STUDIES; SHEET STRUCTURE; SOLID PHASE PEPTIDE SYNTHESIS; TRIPEPTIDE;

AMINO ACIDS; CHLORINE COMPOUNDS; CYCLIZATION; RESINS;

PEPTIDES;

ETHYLAMINE; MACROCYCLIC COMPOUND; ORNITHINE DERIVATIVE; RESIN;

AQUEOUS SOLUTION; ARTICLE; BETA SHEET; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYCLIZATION; DEPROTECTION REACTION; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; PURIFICATION; SOLID; SOLUBILITY; SYNTHESIS;

AMINO ACIDS, AROMATIC; DRUG DESIGN; LACTAMS, MACROCYCLIC; MAGNETIC RESONANCE SPECTROSCOPY; ORNITHINE; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; SOLUBILITY; WATER;

EID: 79955567720     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo102598n     Document Type: Article

References (55)

1. Cascales, L.; Craik, D. J. Org. Biomol. Chem. 2010, 8, 5035-5047
2. Jagadish, K.; Camarero, J. A. Pept. Sci. 2010, 94, 611-616
3. Gerlach, S. L.; Rathinakumar, R.; Chakravarty, G.; Göransson, U.; Wimley, W. C.; Darwin, S. P.; Mondal, D. Pept. Sci. 2010, 94, 617-625
4. Mylne, J. S.; Wang, C. K.; van der Weerden, N. L.; Craik, D. J. Pept. Sci. 2010, 94, 635-646
5. Colgrave, M. L.; Korsinczky, M. J. L.; Clark, R. J.; Foley, F.; Craik, D. J. Pept. Sci. 2010, 94, 665-672
6. Kondejewski, L. H.; Farmer, S. W.; Wishart, D. S.; Kay, C. M.; Hancock, R. E. W.; Hodges, R. S. J. Biol. Chem. 1996, 271, 25261-25268
7. Gibbs, A. C.; Kondejewski, L. H.; Gronwald, W.; Nip, A. M.; Hodges, R. S.; Sykes, B. D.; Wishart, D. S. Nat. Struct. Biol. 1998, 5, 284-288
8. Gibbs, A. C.; Bjorndahl, T. C.; Hodges, R. S.; Wishart, D. S. J. Am. Chem. Soc. 2002, 124, 1203-1213
9. Gallo, S. A.; Wang, W.; Rawat, S. S.; Jung, G.; Waring, A. J.; Cole, A. M.; Lu, H.; Yan, X.; Daly, N. L.; Craik, D. J.; Jiang, S.; Lehrer, R. I.; Blumenthal, R. J. Biol. Chem. 2006, 281, 18787-18792
10. Tran, D.; Tran, P.; Roberts, K.; Osapay, G.; Schaal, J.; Ouellette, A.; Selsted, M. E. Antimicrob. Agents Chemother. 2008, 52, 944-953
11. Späth, J.; Stuart, F.; Jiang, L.; Robinson, J. A. Helv. Chim. Acta 1998, 81, 1726-1738
12. Athanassiou, Z.; Patora, K.; Dias, R. L. A.; Moehle, K.; Robinson, J. A.; Varani, G. Biochemistry 2006, 46, 741-751
13. Fasan, R.; Dias, R. L. A.; Moehle, K.; Zerbe, O.; Obrecht, D.; Mittl, P. R. E.; Grütter, M. G.; Robinson, J. A. ChemBioChem 2006, 7, 515-526
14. Robinson, J. A. Acc. Chem. Res. 2008, 41, 1278-1288
15. Robinson, J. A. Science 2010, 327, 1010-1013
16. Conlan, B. F.; Gillon, A. D.; Craik, D. J.; Anderson, M. A. Pept. Sci. 2010, 94, 573-583
17. Tam, J. P.; Lu, Y.-A.; Yang, J.-L. Biochem. Biophys. Res. Commun. 2000, 267, 783-790
18. Tam, J. P.; Lu, Y.-A.; Yang, J.-L. J. Biol. Chem. 2002, 277, 50450-50456
19. Gottler, L. M.; de la Salud Bea, R.; Shelburne, C. E.; Ramamoorthy, A.; Marsh, E. N. G. Biochemistry 2008, 47, 9243-9250
20. Syud, F. A.; Espinosa, J. F.; Gellman, S. H. J. Am. Chem. Soc. 1999, 121, 11577-11578
21. Stanger, H. E.; Syud, F. A.; Espinosa, J. F.; Giriat, I.; Muir, T.; Gellman, S. H. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 12015-12020
22. Espinosa, J. F.; Syud, F. A.; Gellman, S. H. Protein Sci. 2002, 11, 1492-1505
23. Freire, F.; Gellman, S. H. J. Am. Chem. Soc. 2009, 131, 7970-7972
24. Woods, R. J.; Brower, J. O.; Castellanos, E.; Hashemzadeh, M.; Khakshoor, O.; Russu, W. A.; Nowick, J. S. J. Am. Chem. Soc. 2007, 129, 2548-2558
25. Khakshoor, O.; Demeler, B.; Nowick, J. S. J. Am. Chem. Soc. 2007, 129, 5558-5569
26. Khakshoor, O.; Nowick, J. S. Curr. Opin. Chem. Biol. 2008, 12, 722-729
27. Nowick, J. S. Acc. Chem. Res. 2008, 41, 1319-1330
28. Khakshoor, O.; Nowick, J. S. Org. Lett. 2009, 11, 3000-3003
29. Khakshoor, O.; Lin, A. J.; Korman, T. P.; Sawaya, M. R.; Tsai, S.-C.; Eisenberg, D.; Nowick, J. S. J. Am. Chem. Soc. 2010, 132, 11622-11628
30. Tatko, C. D.; Waters, M. L. J. Am. Chem. Soc. 2002, 124, 9372-9373
31. Zheng, J; Liu, C.; Sawaya, M. R.; Vadla, B.; Khan, S.; Woods, R. J.; Eisenberg, D.; Goux, W. J.; Nowick, J. S. J. Am. Chem. Soc. 2011, 133, 3144-3157
32. Nowick, J. S.; Tsai, J. H.; Bui, Q.-C. D.; Maitra, S. J. Am. Chem. Soc. 1999, 121, 8409-8410
33. Nowick, J. S.; Chung, D. M.; Maitra, K.; Maitra, S.; Stigers, K. D.; Sun, Y. J. Am. Chem. Soc. 2000, 122, 7654-7661
34. Nowick, J. S.; Lam, K. S.; Khasanova, T. V.; Kemnitzer, W. E.; Maitra, S.; Mee, H. T.; Liu, R. J. Am. Chem. Soc. 2002, 124, 4972-4973
35. Nowick, J. S.; Chung, D. M. Angew. Chem., Int. Ed. 2003, 42, 1765-1768
36. Nowick, J. S.; Brower, J. O. J. Am. Chem. Soc. 2003, 125, 876-877
37. Chung, D. M.; Nowick, J. S. J. Am. Chem. Soc. 2004, 126, 3062-3063
38. Chung, D. M.; Dou, Y.; Baldi, P.; Nowick, J. S. J. Am. Chem. Soc. 2005, 127, 9998-9999
39. Nowick, J. S. Org. Biomol. Chem. 2006, 4, 3869-3885
40. Smith, C. K.; Regan, L. Science 1995, 270, 980-982
41. Smith, C. K.; Regan, L. Acc. Chem. Res. 1997, 30, 153-161
42. Wouters, M. A.; Curmi, P. M. G. Proteins: Struct., Funct., Genet. 1995, 22, 119-131
43. Most standard peptide synthesis procedures followed those in the "Synthesis Notes" section of the 2009/2010 Novabiochem catalog.
44. Either Fmoc*-Hao-OH or Fmoc-Hao-OH was used to introduce the Hao residue. Fmoc*-Hao-OH has been described previously in ref 10b. Fmoc* refers to the 2,7-di- tert -butyl-Fmoc group. This more soluble analogue of the Fmoc group is described in: Stigers, K. D.; Koutroulis, M. R.; Chung, D. M.; Nowick, J. S. J. Org. Chem. 2000, 65, 3858-3860 For details of the preparation of Fmoc-Hao-OH, see the Supporting Information.
45. Montalbetti, C. A. G. N.; Falque, V. Tetrahedron 2005, 61, 10827-10852
46. Hood, C. A.; Fuentes, G.; Patel, H.; Page, K.; Menakuru, M.; Park, J. H. J. Pept. Sci. 2008, 14, 97-101
47. Valeur, E.; Bradley, M. Chem. Soc. Rev. 2009, 38, 606-631
48. In the cyclization step, most macrocyclic peptides were synthesized using HCTU/DIEA/DMF. Cyclization using HCTU/DIEA/DMF produces yellowish impurities that remain after deprotection with TFA. When these colored impurities proved difficult to remove by HPLC purification, cyclization was alternatively performed with HBTU/HOBt/N-methylmorpholine/DMF. (15)
49. HPLC analysis of cyclic peptide 8a shows comparable purities of the crude products from cyclization at 0.5 and 10 mM concentrations, indicating that macrocyclization causes no or little polymerization. For details, see Figure S1 in the Supporting Information. If polymers or oligomers were to form under these conditions, the HPLC traces from cyclization at 10 mM would show impurities substantially greater than those at 0.5 mM.
50. 2O (9:1) with water suppression to observe amide resonances and allow sequence-specific assignment of the resonances.
51. NOEs between the two Hao units cannot be observed due to symmetry.
52. 2O, and the NOEs involving these protons cannot be observed under the conditions of the ROESY experiments.
53. Yao, S.; Howlett, G. J.; Norton, R. S. J. Biomol. NMR 2000, 16, 109-119
54. Cohen, Y.; Avram, L.; Frish, L. Angew. Chem., Int. Ed. 2005, 44, 520-554
55. δOrn value of 1.3 ppm in a chloroform solution. For details, see ref 10c.